Clinical Trial Update: Open-label Extension for Phase 3 Clinical Trials of Simufilam [Phase 3]

View source ↗

Summary

Open-label extension updates for Phase 3 trials of Simufilam in Alzheimer's disease have been reported. The trials were terminated and results were posted on 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Simufilam (simufilam)

Snippet

Sponsor: Cassava Sciences, Inc. | Conditions: Alzheimer Disease | Phase 3 | Status: TERMINATED | Results posted: 2025-05-14